DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisolone (Prednisolone) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (183)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 183   Next >>

Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-08-27

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Pneumonia, Cholecystitis Acute, Pyrexia, Enterocolitis, Herpes Zoster

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Inc424
    Dosage: 30 mg, bid
    Administration route: Oral
    Indication: Myelofibrosis
    Start date: 2011-12-12
    End date: 2012-03-31

Inc424
    Dosage: unk
    Administration route: Oral
    Start date: 2012-04-02
    End date: 2012-04-09

Inc424
    Dosage: 20 mg, qd
    Start date: 2012-05-25
    End date: 2012-08-18

Prednisolone
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Platelet Count Decreased
    Start date: 2004-05-18

Other drugs received by patient: Lasix; MS Contin; Acetaminophen; Merislon; Lansoprazole; Exjade; Pursennid; Terranas; Amoban; Acetaminophen; Maxalt; Alosenn; Laxoberon; Celecoxib; Lyrica; Exjade; Morphine; Halcion; Magnesium Oxide; Vitamin B12; Uloric



Possible Prednisolone side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-26

Patient: 72 year old male

Reactions: Productive Cough, Optic Atrophy, Blood Creatine Phosphokinase Increased, Pneumonia, Normal Tension Glaucoma, Muscular Weakness, Pyrexia, Polymyositis, Aldolase Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Azathioprine Sodium
    Dosage: 50 mg, unk
    Indication: Polymyositis
    Start date: 2007-10-01

Cyclosporine
    Dosage: 200 mg, qd
    Start date: 2007-11-01

Cyclosporine
    Dosage: 150 mg, qd
    Indication: Polymyositis
    Start date: 2007-05-01

Cyclosporine
    Dosage: 175 mg, qd

Prednisolone
    Dosage: 6 mg, unk
    Administration route: Oral
    Start date: 2008-02-02

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Polymyositis
    Start date: 2007-05-01



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-24

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 72 year old male

Reactions: Optic Atrophy, Productive Cough, Blood Creatine Phosphokinase Increased, Pneumonia, Normal Tension Glaucoma, Muscular Weakness, Pyrexia, Polymyositis, Aldolase Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Azathioprine Sodium
    Dosage: 50 mg, unk
    Indication: Polymyositis
    Start date: 2007-10-01

Cyclosporine
    Dosage: 200 mg, qd
    Start date: 2007-11-01

Cyclosporine
    Dosage: 150 mg, qd
    Indication: Polymyositis
    Start date: 2007-05-01

Cyclosporine
    Dosage: 175 mg, qd

Prednisolone
    Dosage: 6 mg, unk
    Administration route: Oral
    Start date: 2008-02-02

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Polymyositis
    Start date: 2007-05-01



Possible Prednisolone side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)

Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 30 mg/m2 x 1/4 week
    Start date: 2011-03-16

Adriamycin PFS
    Dosage: 40 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Carboplatin
    Dosage: 250 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 350 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Etoposide
    Dosage: 100 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Prednisolone
    Dosage: 1mg/kg x 1/2 week
    Start date: 2011-12-13
    End date: 2011-12-14

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Start date: 2011-03-16

Prednisolone
    Dosage: 2 mg/m2, 1x/day
    Administration route: Oral
    Start date: 2011-03-24

Ranimustine
    Dosage: 60 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-16

Vincristine Sulfate
    Dosage: 1 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Vindesine Sulfate
    Dosage: 2.4 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-08-23

Patient: male, weighing 50.0 kg (110.0 pounds)

Reactions: Renal Impairment, C-Reactive Protein Increased, Neoplasm Malignant, Neoplasm Progression, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2012-01-06
    End date: 2012-01-09

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-12-14
    End date: 2011-12-29

Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-20
    End date: 2011-10-03

Etodolac
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma

Prednisolone
    Dosage: 5 mg
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-21
    End date: 2011-09-01

Zometa
    Dosage: unk ukn, unk
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-06-27

Other drugs received by patient: Allopurinol; Benidipine Hydrochloride; Vitamin B12; Limaprost Alfadex; Lansoprazole; Limaprost Alfadex; Flivas; Acetaminophen



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-23

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s

Cyclophosphamide

Cyclophosphamide

Doxorubicin Hydrochloride

Doxorubicin Hydrochloride

Etoposide

Etoposide

Prednisolone
    Administration route: Oral

Procarbazine Hydrochloride
    Administration route: Oral

Vincristine



Possible Prednisolone side effects in male

Reported by a physician from United Kingdom on 2012-08-21

Patient: male

Reactions: Pelvic Pain, Pyrexia, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Hepatosplenic T-Cell Lymphoma, Crohn's Disease, Sepsis, Platelet Count Decreased, Diabetic Ketoacidosis, Neutropenia, Rectal Discharge, Leukopenia, Influenza Like Illness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Azathioprine Sodium
    Dosage: 2.5 mg/kg
    Indication: Crohn's Disease

Azathioprine Sodium
    Start date: 2002-01-01
    End date: 2006-09-01

Azathioprine Sodium
    Start date: 2001-06-01

Mercaptopurine
    Indication: Crohn's Disease

Prednisolone
    Indication: Product Used FOR Unknown Indication

Remicade
    Indication: Crohn's Disease
    End date: 2005-09-29

Remicade
    Dosage: stopped in february - march (3rd infusion)
    End date: 2006-02-01

Other drugs received by patient: Metronidazole; Vitamin B-12



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-08-20

Patient: female, weighing 47.7 kg (104.9 pounds)

Reactions: Cardio-Respiratory Arrest, Metabolic Acidosis, Hepatic Function Abnormal, Arthralgia, Disseminated Intravascular Coagulation, Platelet Count Decreased, Pyrexia, Device Related Infection, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Remicade
    Indication: Rheumatoid Arthritis
    Start date: 2011-12-06

Remicade
    Start date: 2010-09-03

Remicade
    Dosage: 20th dose
    Start date: 2012-06-01

Remicade
    Start date: 2009-08-21

Other drugs received by patient: Folic Acid; Edirol; Lansoprazole; Cefazolin Sodium; Warfarin Sodium



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-17

Patient: male

Reactions: Pneumonia, Viral Infection, Diabetes Mellitus, Pyrexia, C-Reactive Protein Decreased, Eosinophil Count Increased, Glycosylated Haemoglobin Increased, Haematocrit Decreased, Heart Rate Decreased, Respiratory Failure, Blood Glucose Increased, White Blood Cell Count Increased, Influenza

Drug(s) suspected as cause:
Clozaril
    Dosage: 25 mg
    Administration route: Oral
    Start date: 2011-02-02
    End date: 2011-02-04

Clozaril
    Dosage: 50 mg
    Administration route: Oral
    Start date: 2011-02-05
    End date: 2011-02-08

Clozaril
    Dosage: 125 mg
    Administration route: Oral
    Start date: 2011-05-01
    End date: 2011-05-04

Clozaril
    Dosage: 225 mg
    Administration route: Oral
    Start date: 2011-05-19
    End date: 2011-06-01

Clozaril
    Dosage: 75 mg
    Administration route: Oral
    Start date: 2011-03-09
    End date: 2011-03-15

Clozaril
    Dosage: 100 mg
    Administration route: Oral
    Start date: 2011-04-28
    End date: 2011-04-30

Clozaril
    Dosage: 300 mg
    Administration route: Oral
    Start date: 2011-06-17

Clozaril
    Dosage: 200 mg
    Administration route: Oral
    Start date: 2011-05-14
    End date: 2011-05-18

Clozaril
    Dosage: 75 mg
    Start date: 2011-02-09
    End date: 2011-02-15

Clozaril
    Dosage: 100 mg
    Administration route: Oral
    Start date: 2011-02-16
    End date: 2011-02-22

Clozaril
    Dosage: 50 mg
    Administration route: Oral
    Start date: 2011-03-02
    End date: 2011-03-08

Clozaril
    Dosage: 100 mg
    Administration route: Oral
    Start date: 2011-03-16
    End date: 2011-03-22

Clozaril
    Dosage: 12.5 mg
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-04-21

Clozaril
    Dosage: 175 mg
    Administration route: Oral
    Start date: 2011-05-09
    End date: 2011-05-13

Clozaril
    Dosage: 25 mg, unk
    Start date: 2011-04-22
    End date: 2011-04-23

Clozaril
    Dosage: 250 mg
    Administration route: Oral
    Start date: 2011-06-02
    End date: 2011-06-08

Clozaril
    Dosage: 275 mg
    Administration route: Oral
    Start date: 2011-06-09
    End date: 2011-06-16

Clozaril
    Dosage: 50 mg
    Administration route: Oral
    Start date: 2011-04-24
    End date: 2011-04-24

Clozaril
    Dosage: 12.5 mg,
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-02-01
    End date: 2011-02-01

Clozaril
    Dosage: 75 mg
    Administration route: Oral
    Start date: 2011-04-25
    End date: 2011-04-27

Clozaril
    Dosage: 150 mg
    Administration route: Oral
    Start date: 2011-05-05
    End date: 2011-05-08

Prednisolone
    Dosage: 15 mg, qd
    Start date: 2011-02-22
    End date: 2011-02-28

Prednisolone
    Dosage: 5 mg, daily
    Start date: 2011-03-08
    End date: 2011-03-14

Prednisolone
    Dosage: 10 mg, unk
    Start date: 2011-03-01
    End date: 2011-03-07

Other drugs received by patient: Rhubarb; Invega; Nitrazepam; Biperiden Hydrochloride TAB; Sitagliptin Phosphate; Loxoprofen; Risperdal; Tamiflu; Invega; Lithium Carbonate; Lorazepam; Ronfleman; Risperdal; Flunitrazepam; Sodium Picosulfate; Ronfleman; Ronfleman; Ronfleman; Zithromax; Verapamil HCL; Invega; Biperiden Hydrochloride TAB; Sitagliptin Phosphate; Lorazepam; Loxoprofen; Risperdal; Rhubarb; Valproate Sodium



Possible Prednisolone side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-16

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Pneumonia, Cholecystitis Acute, Pyrexia, Herpes Zoster

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Inc424
    Dosage: unk
    Administration route: Oral
    Start date: 2012-04-02
    End date: 2012-04-09

Inc424
    Dosage: 20 mg, qd
    Start date: 2012-05-25

Inc424
    Dosage: 30 mg, bid
    Administration route: Oral
    Indication: Myelofibrosis
    Start date: 2011-12-12
    End date: 2012-03-31

Prednisolone
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Platelet Count Decreased
    Start date: 2004-05-18

Other drugs received by patient: Exjade; Vitamin B12; Halcion; Lansoprazole; Lasix; Celecoxib; Alosenn; Terranas; MS Contin; Maxalt; Amoban; Exjade; Acetaminophen; Uloric; Merislon; Magnesium Oxide; Pursennid; Laxoberon; Morphine; Acetaminophen; Lyrica



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-08-14

Patient: male, weighing 43.0 kg (94.6 pounds)

Reactions: Pneumonia Aspiration, Urine Output Decreased, Pyrexia, Haemothorax, Cardio-Respiratory Arrest, Hypopnoea, Respiratory Failure, Decreased Immune Responsiveness, Pleural Infection, Depressed Level of Consciousness, Hypoxia, Blood Pressure Decreased, Cough, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Etanercept
    Start date: 2011-02-15

Etanercept
    Start date: 2011-03-19
    End date: 2011-03-19

Etanercept
    Start date: 2011-03-26
    End date: 2011-03-26

Etanercept

Etanercept
    Indication: Rheumatoid Arthritis
    Start date: 2009-06-01
    End date: 2009-10-01

Etanercept
    Start date: 2011-04-02
    End date: 2011-04-02

Humira
    Indication: Rheumatoid Arthritis
    Start date: 2011-04-15
    End date: 2011-04-29

Methotrexate
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2011-04-14
    End date: 2011-04-21

Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2011-03-24
    End date: 2011-05-04



Possible Prednisolone side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: 61 year old female

Reactions: Mucosal Inflammation, Nausea, Pyrexia, Diffuse Large B-Cell Lymphoma Recurrent, Oral Herpes

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Methotrexate
    Indication: Diffuse Large B-Cell Lymphoma

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-08-13

Patient: male, weighing 43.0 kg (94.6 pounds)

Reactions: Pneumonia Aspiration, Urine Output Decreased, Pyrexia, Haemothorax, Cardio-Respiratory Arrest, Decreased Immune Responsiveness, Hypopnoea, Respiratory Failure, Pleural Infection, Hypoxia, Depressed Level of Consciousness, Blood Pressure Decreased, Cough, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Etanercept

Etanercept
    Start date: 2011-02-15

Etanercept
    Start date: 2011-04-02
    End date: 2011-04-02

Etanercept
    Start date: 2011-03-19
    End date: 2011-03-19

Etanercept
    Indication: Rheumatoid Arthritis
    Start date: 2009-06-01
    End date: 2009-10-01

Etanercept
    Start date: 2011-03-26
    End date: 2011-03-26

Humira
    Indication: Rheumatoid Arthritis
    Start date: 2011-04-15
    End date: 2011-04-29

Methotrexate
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2011-04-14
    End date: 2011-04-21

Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2011-03-24
    End date: 2011-05-04



Possible Prednisolone side effects in 40 year old female

Reported by a physician from Japan on 2012-08-10

Patient: 40 year old female

Reactions: Gastrointestinal Haemorrhage, Trigeminal Neuralgia, RED Blood Cell Abnormality, Disseminated Intravascular Coagulation, Pyrexia, Circulatory Collapse, Staphylococcal Bacteraemia, Melaena, Hepatitis Fulminant, Hepatosplenomegaly, White Blood Cell Count Increased, Plasmapheresis, Anaemia, Cardiac Valve Vegetation, Alanine Aminotransferase Increased, Thrombotic Thrombocytopenic Purpura, Convulsion, Haemodialysis, Haemoglobin Decreased, Renal Impairment, Oliguria, Aspartate Aminotransferase Increased, Blood Smear Test Abnormal, Platelet Count Decreased, Transfusion, Haemorrhagic Diathesis, Altered State of Consciousness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: unk
    Start date: 2007-10-01
    End date: 2009-10-28

Tracleer
    Dosage: 62.5 mg, bid
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2008-07-10
    End date: 2009-09-30

Tracleer
    Dosage: 62.5 mg, qd
    Administration route: Oral
    Start date: 2008-07-02
    End date: 2008-07-09

Other drugs received by patient: Beraprost Sodium; Sarpogrelate Hydrochloride; Carbocisteine; Meloxicam; Trimebutine Maleate; Omeprazole



Possible Prednisolone side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-08-07

Patient: 40 year old female

Reactions: Thrombosis, Blood Creatine Phosphokinase Increased, Enterococcal Infection, Pyrexia, Decubitus Ulcer, Skin Ulcer, Systemic Sclerosis, Enterobacter Test Positive, White Blood Cell Count Decreased, FAT Necrosis, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Haemoglobin Decreased, Overlap Syndrome, Arthralgia, Aspartate Aminotransferase Increased, Systemic Lupus Erythematosus, Swelling, Platelet Count Decreased, Necrotising Fasciitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Azathioprine
    Indication: Overlap Syndrome

Azathioprine
    Indication: Systemic Lupus Erythematosus

Hydroxychloroquine Sulfate
    Indication: Systemic Lupus Erythematosus

Hydroxychloroquine Sulfate
    Indication: Overlap Syndrome

Prednisolone
    Dosage: 10 mg,
    Indication: Overlap Syndrome

Prednisolone
    Dosage: 10 mg,
    Indication: Systemic Lupus Erythematosus



Possible Prednisolone side effects in 56 year old female

Reported by a pharmacist from Japan on 2012-08-03

Patient: 56 year old female

Reactions: Flushing, Drug Eruption, Malaise, Diabetes Mellitus, Hypertrophy, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adrenocortical Hormone
    Administration route: Topical
    Indication: Drug Eruption

Antihistamines
    Indication: Drug Eruption

Darunavir Ethanolate
    Administration route: Oral
    Indication: HIV Infection

Emtricitabine / Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: HIV Infection

Prednisolone
    Administration route: Oral

Prednisolone
    Administration route: Oral
    Indication: Drug Eruption

Prezista
    Administration route: Oral
    Indication: Antiretroviral Therapy

Ritonavir
    Indication: HIV Infection

Sulfamethoxazole and Trimethoprim
    Indication: Antifungal Prophylaxis



Possible Prednisolone side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30

Patient: 82 year old female

Reactions: Confusional State, Pyrexia, Lymphoma

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Mabthera
    Indication: B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma

Other drugs received by patient: Methotrexate



Possible Prednisolone side effects in 77 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20

Patient: 77 year old male

Reactions: Abscess Fungal, Candida Sepsis, Pyrexia, Loss of Consciousness, Pseudomonal Sepsis, Pleural Effusion, Tachypnoea, Oedema, Thrombocytopenia, Anaemia, Pseudomonas Infection, Pancytopenia, Staphylococcal Sepsis, Ascites, Staphylococcal Infection, Sinus Tachycardia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ceftazidime
    Indication: Staphylococcal Infection

Ceftazidime
    Indication: Pseudomonas Infection

Imipenem and Cilastatin
    Indication: Pseudomonas Infection

Imipenem and Cilastatin
    Indication: Staphylococcal Infection

Isepamicin

Prednisolone
    Dosage: 50 mg, unk
    Indication: Pemphigus

Teicoplanin
    Indication: Pseudomonas Infection

Teicoplanin
    Indication: Staphylococcal Infection



Possible Prednisolone side effects in 37 year old male

Reported by a health professional (non-physician/pharmacist) from Iran (Islamic Republic OF) on 2012-07-19

Patient: 37 year old male

Reactions: Renal Impairment, Viral Infection, Pyrexia, Renal Pain, Blood Creatinine Increased

Drug(s) suspected as cause:
Azathioprine
    Indication: Renal Transplant

Cyclosporine
    Indication: Renal Transplant

Methylprednisolone
    Dosage: 2 courses of methylprednisolone pulses within three weeks
    Indication: Renal Transplant

Mycophenolate Mofetil
    Indication: Renal Transplant

Prednisolone
    Indication: Renal Transplant



Possible Prednisolone side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: 60 year old female

Reactions: Drug Resistance, Blood Creatine Phosphokinase Increased, Arthralgia, Disease Recurrence, Hypoxia, Atypical Mycobacterial Infection, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclosporine
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Dermatomyositis

Cyclosporine
    Dosage: 50 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Dermatomyositis

Prednisolone
    Dosage: 12 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 15 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 40 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 45 mg, unk
    Administration route: Oral



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Prednisolone side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: 60 year old female

Reactions: Blood Creatine Phosphokinase Increased, Drug Resistance, Arthralgia, Disease Recurrence, Atypical Mycobacterial Infection, Hypoxia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclosporine
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Dermatomyositis

Cyclosporine
    Dosage: 50 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 45 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 40 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Dermatomyositis

Prednisolone
    Dosage: 12 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 15 mg, unk
    Administration route: Oral



Possible Prednisolone side effects in

Reported by a physician from United Kingdom on 2012-07-17

Patient:

Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole



Possible Prednisolone side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-17

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Pneumonia, Cholecystitis Acute, Pyrexia, Herpes Zoster

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Inc424
    Dosage: unk
    Administration route: Oral
    Start date: 2012-04-02
    End date: 2012-04-09

Inc424
    Dosage: 20 mg, qd
    Start date: 2012-05-25

Inc424
    Dosage: 30 mg, bid
    Administration route: Oral
    Indication: Myelofibrosis
    Start date: 2011-12-12
    End date: 2012-03-31

Prednisolone
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Platelet Count Decreased
    Start date: 2004-05-18

Other drugs received by patient: Halcion; Lyrica; Pursennid; Amoban; Lasix; Morphine; Magnesium Oxide; Exjade; Lansoprazole; Acetaminophen; Vitamin B12; Celecoxib; MS Contin; Acetaminophen



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-07-13

Patient: female

Reactions: Gastrointestinal Haemorrhage, Trigeminal Neuralgia, RED Blood Cell Abnormality, Disseminated Intravascular Coagulation, Pyrexia, Circulatory Collapse, Staphylococcal Bacteraemia, Melaena, White Blood Cell Count Increased, Hepatitis Fulminant, Hepatosplenomegaly, Mechanical Ventilation, Alanine Aminotransferase Increased, Plasmapheresis, Anaemia, Thrombotic Thrombocytopenic Purpura, Convulsion, Haemodialysis, Haemoglobin Decreased, Renal Impairment, Oliguria, Aspartate Aminotransferase Increased, Blood Smear Test Abnormal, Transfusion, Haemorrhagic Diathesis, Platelet Count Decreased, Altered State of Consciousness, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: unk
    Start date: 2007-10-01
    End date: 2009-10-28

Tracleer
    Dosage: 62.5 mg, bid
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2008-07-10
    End date: 2009-09-30

Tracleer
    Dosage: 62.5 mg, qd
    Administration route: Oral
    Start date: 2008-07-02
    End date: 2008-07-09

Other drugs received by patient: Carbocisteine; Omeprazole; Sarpogrelate Hydrochloride; Beraprost Sodium; Meloxicam; Trimebutine Maleate



Possible Prednisolone side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir



Possible Prednisolone side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-10

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Cholecystitis Acute, Pyrexia, Herpes Zoster

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Inc424
    Dosage: unk
    Administration route: Oral
    Start date: 2012-04-02
    End date: 2012-04-09

Inc424
    Dosage: 30 mg, bid
    Administration route: Oral
    Indication: Myelofibrosis
    Start date: 2011-12-12
    End date: 2012-03-31

Inc424
    Dosage: 20 mg, qd
    Start date: 2012-05-25

Prednisolone
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Platelet Count Decreased
    Start date: 2004-05-18

Other drugs received by patient: Lansoprazole; Celecoxib; Lasix; Vitamin B12; Magnesium Oxide; Exjade; Morphine; MS Contin; Halcion



Possible Prednisolone side effects in 50 year old female

Reported by a physician from Portugal on 2012-07-10

Patient: 50 year old female

Reactions: Weight Decreased, Biliary Cirrhosis Primary, Steatorrhoea, Wrist Fracture, Ganglioneuroma, Cholestasis, Pyrexia, Multiple Fractures, Hepatic Steatosis, Chest Pain, Sjogren's Syndrome, RIB Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adalimumab
    Indication: Rheumatoid Arthritis

Alendronate Sodium
    Indication: Rheumatoid Arthritis
    Start date: 2003-01-01

Azathioprine
    Dosage: frequency: everyday (qd)
    Indication: Rheumatoid Arthritis
    Start date: 1997-12-01
    End date: 2004-06-01

Azulfidine
    Dosage: frequency: everyday (qd)
    Indication: Rheumatoid Arthritis

Etanercept
    Indication: Rheumatoid Arthritis

Methotrexate

Methotrexate
    Indication: Rheumatoid Arthritis
    Start date: 1995-09-01
    End date: 1997-09-01

Methotrexate

Methotrexate
    Start date: 1996-11-01
    End date: 1997-01-01

Prednisolone
    Dosage: frequency: everyday (qd). dose reported: 5 mg qd} 10 mg qd
    Indication: Rheumatoid Arthritis

Prednisolone
    Dosage: frequency: everyday (qd)

Rituximab
    Indication: Rheumatoid Arthritis

Rituximab

Other drugs received by patient: Hydroxychloroquine Sulfate; Hydroxychloroquine Sulfate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017